Circulating tumor cells (CTCs) and circulating cell free DNA (ccfDNA) represent a liquid biopsy of a tumor allowing real time disease monitoring especially in advanced stages of cancer, but their analysis is technically challenging.
Evaluation of the liquid biopsy for the detection of brafv600e mutation in metastatic melanoma patients / Salvianti, Francesca; Massi, Daniela; De Giorgi, Vincenzo; Gori, Alessia; Pazzagli, Mario; Pinzani, Pamela. - In: DISEASE MARKERS. SECTION A, CANCER BIOMARKERS. - ISSN 1574-0153. - ELETTRONICO. - 26:(2019), pp. 271-279. [10.3233/CBM-181647]
Evaluation of the liquid biopsy for the detection of brafv600e mutation in metastatic melanoma patients
Salvianti, Francesca;Massi, Daniela;DE GIORGI, VINCENZO;Pazzagli, Mario;Pinzani, Pamela
2019
Abstract
Circulating tumor cells (CTCs) and circulating cell free DNA (ccfDNA) represent a liquid biopsy of a tumor allowing real time disease monitoring especially in advanced stages of cancer, but their analysis is technically challenging.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
